Logo
investor hub

Phase 2b PARA_005 Trial Results Video

Paradigm Biopharmaceuticals Ltd is pleased to announce the results of its phase 2b randomised double-blind placebo-controlled multi-centre clinical trial.


0

likes

0

questions

0

company answers

Ask a question


Your question will be sent privately to Paradigm Biopharmaceuticals. The company may choose to make this question public.

Investor Q&As

Start the conversation

Ask Paradigm Biopharmaceuticals a question about this update.